Insights
But where will I put my Christmas tree?
07 Nov 2025This is a question a lot of Conveyancers will be asked at this time of year. Christmas is still a popular time for people to choose to move house, but for some, this was not their choice - unexpected delays have led to a Christmas completion.
Post-16 Education and Skills White Paper
07 Nov 2025The UK Government’s Post-16 Education and Skills White Paper has provided much for the higher education (HE) sector to digest.
Your business is considering decentralised manufacturing for a product - what are the steps you need to take?
06 Nov 2025As discussed in our previous article, the UK is the first country to have implemented a framework to allow Point of Care (POC) and Modular Manufacturing (MM), together known as Decentralised Manufacturing (DM). This is a really exciting step, particularly for the area of personalised medicines, but there are certain considerations and mandatory steps for businesses to take before they implement DM processes.
MHRA and NICE collaboration: A new era for accelerating patient access to medicines
04 Nov 2025The Medicines and Healthcare products Regulatory Agency (MHRA) and the National Institute for Health and Care Excellence (NICE) have provided more details about a significant collaboration aimed at transforming the regulatory and health technology assessment processes in the UK. This MHRA and NICE partnership marks a pivotal step in expediting patient access to medicines while enhancing the UK’s position as a global leader in life sciences.
€160m fine warning of dangers of imposing resale prices on customers or interfering with discounts
04 Nov 2025Businesses might want to protect their downstream market, but this is riddled with dangers when they look to impose conditions on the minimum or actual prices or discount conditions on their customers. The €157m fines on Gucci, Chloé and Loewe provide a big warning sign to businesses of engaging with this.
Employment Rights Bill: Key implications for the Pharmaceuticals and Life Sciences Sector
04 Nov 2025The Employment Rights Bill will introduce significant changes impacting employers across all industries. For pharmaceuticals and life sciences organisations, these changes come as workforce expectations evolve and sustainability becomes a marker of good governance. Employers that align legal compliance with fair and transparent employment practices will be best placed to attract and retain skilled talent in a competitive market.
